<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02333708</url>
  </required_header>
  <id_info>
    <org_study_id>2013-A00273-44</org_study_id>
    <nct_id>NCT02333708</nct_id>
  </id_info>
  <brief_title>Study of Circulating Microparticles in Giant Cell Arteritis</brief_title>
  <acronym>MicroGiant</acronym>
  <official_title>Study of Circulating Microparticles in Giant Cell Arteritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Caen</source>
  <brief_summary>
    <textblock>
      To demonstrate that microparticles (MPs), having a powerful procoagulant potential, are in
      larger amounts in the blood of patients with histologically proven giant cell arteritis
      (GCA), compared with patients matched for age, sex and with or without inflammatory syndrome.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Level of microparticles in the blood of patients with histologically proven giant cell arteritis.</measure>
    <time_frame>Baseline</time_frame>
    <description>Level of microparticles (MPs) in the blood of patients with histologically proven giant cell arteritis (GCA), compared with patients matched for age, sex and with or without inflammatory syndrome.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Giant Cell Arteritis</condition>
  <condition>Acute Phase</condition>
  <arm_group>
    <arm_group_label>GCA group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Inflammatory syndrome (without GCA) group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Without inflammatory syndrome and without GCA group</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood sample</intervention_name>
    <arm_group_label>GCA group</arm_group_label>
    <arm_group_label>Inflammatory syndrome (without GCA) group</arm_group_label>
    <arm_group_label>Without inflammatory syndrome and without GCA group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        primary and secondary care hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        For GCA group:

        Inclusion Criteria:

          -  Men and women ≥ 18 years of age Patient affiliated to social security regimen

          -  Informed and having signed the consent form to take part in the study.

          -  Diagnosis of GCA, meeting at least 3 of the following 5 American College of
             Rheumatology (ACR) criteria for the diagnosis of GCA, including inflammatory syndrome
             and having

               -  Either temporal artery biopsy showing characteristic GCA abnormality

               -  Or inflammatory arteritis on imaging examination

        Exclusion Criteria:

          -  Persons under protection of the court or guardianship

          -  Inability to understand or to follow study procedures

          -  Dementia

          -  cancer diagnosed within the previous 5 years (except for non-melanoma skin cancer or
             in situ carcinoma of the cervix)non-contributory or inconclusive temporal artery
             biopsy

          -  Any conditions that might interfere with MPs level: diabetes, recent endo-arterial
             gesture, current treatment with corticosteroids.

          -  Participation in another ongoing clinical trial Current anticoagulant therapy

          -  Active infectious disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Boris BIENVENU, MD, PhD,</last_name>
    <phone>+33231064579</phone>
    <email>bienvenu-b@chu-caen.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Côte de Nacre</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boris BIENVENU</last_name>
      <phone>+33231064579</phone>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 5, 2015</study_first_submitted>
  <study_first_submitted_qc>January 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2015</study_first_posted>
  <last_update_submitted>September 12, 2016</last_update_submitted>
  <last_update_submitted_qc>September 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arteritis</mesh_term>
    <mesh_term>Giant Cell Arteritis</mesh_term>
    <mesh_term>Polymyalgia Rheumatica</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

